Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model.
about
A new fork for clinical application: targeting forkhead transcription factors in cancerAdenovirus 5 E1A enhances histone deacetylase inhibitors-induced apoptosis through Egr-1-mediated Bim upregulationBikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatmentDown-regulation of c9orf86 in human breast cancer cells inhibits cell proliferation, invasion and tumor growth and correlates with survival of breast cancer patientsProteasome inhibition enhances the killing effect of BikDD gene therapyThe pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer.A novel hTERT promoter-driven E1A therapeutic for ovarian cancer.Cancer targeted gene therapy of BikDD inhibits orthotopic lung cancer growth and improves long-term survival.
P2860
Q24651455-5F7183D2-540E-4633-8C2E-BF04D2E725CCQ34200411-D5D3CE5F-F72E-43A2-8643-05A6CE2C7B60Q34632169-8A46A307-3680-46F4-9D4A-9AB7C829E9E6Q34972178-453EC50F-73D5-467E-9B60-28BB3EED237DQ35440131-19B292FB-58E4-48A3-8418-27E6472D7A00Q37362905-820C8C58-3A89-457B-BDE7-8F667D8DDFA9Q37381467-EC52BA4A-FB1E-493A-908B-64D40015A631Q37390617-0604AC2B-927A-4065-A5B1-17B0CB9FBBD6
P2860
Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Mutant Bik expression mediated ...... ast tumors in an animal model.
@en
type
label
Mutant Bik expression mediated ...... ast tumors in an animal model.
@en
prefLabel
Mutant Bik expression mediated ...... ast tumors in an animal model.
@en
P2093
P2860
P356
P1433
P1476
Mutant Bik expression mediated ...... ast tumors in an animal model.
@en
P2093
Hortobagyi GN
Lopez-Berestein G
P2860
P2888
P304
P356
10.1038/SJ.CGT.7700945
P577
2006-03-03T00:00:00Z
P6179
1041704589